Tevogen Inc. — Form 8-K Summary
Business context and reporting period
The filing reports an event dated September 29, 2026, for Tevogen Inc. (Nasdaq: TVGN; warrants: TVGNW). It is an 8-K under Item 8.01, not a periodic financial-results filing.
Key financial metrics
The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating financial figures.
Material event
On September 29, 2026, Tevogen received written notice from Nasdaq that it had regained compliance with the $50 million minimum market value of listed securities requirement under Nasdaq Listing Rule 5450(b)(2)(A), applicable to continued listing on the Nasdaq Global Market. Nasdaq closed the matter.
The company said it issued a press release announcing the regained compliance on September 30, 2026; the release was furnished as Exhibit 99.1.
Outlook, risks, and contingencies
The filing gives no financial guidance or broader outlook and identifies no additional risks, contingencies, or unusual financial items.
Important facts to verify
- Confirm the Nasdaq notice and that the compliance matter remains closed.
- Review the September 30, 2026 press release for any additional detail about the compliance determination.